Breast cancer in male-to-female (MtF) transgender patients: is hormone receptor negativity a feature?
- PMID: 25994431
- PMCID: PMC4442180
- DOI: 10.1136/bcr-2015-209396
Breast cancer in male-to-female (MtF) transgender patients: is hormone receptor negativity a feature?
Abstract
A 41-year-old male-to-female (MtF) transgender patient presented with a symptomatic tender lump in the left breast. There was no family history of breast cancer. She had been receiving estrogen therapy for 14 years to maintain her secondary sexual characteristics. Triple assessment revealed a 13 mm triple-negative grade 3 invasive ductal carcinoma. The tumour was completely excised following a left wide local excision and sentinel lymph node biopsy. There was no regional lymph node involvement. She was referred to the oncologist for adjuvant chemotherapy and radiotherapy.
2015 BMJ Publishing Group Ltd.
Figures
References
-
- Cancer Research UK. Breast cancer incidence in males. http://www.cancerresearchuk.org/cancer-info/cancerstats/types/breast/inc... (accessed 12 Dec 2014).
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous